News
-
-
-
COMMUNIQUÉ DE PRESSE
Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG
Courts of Basel-Stadt have revoked the bankruptcy of Kinarus Therapeutics Holding AG, a SIX Swiss Exchange listed therapeutic drug development company. The revocation is a condition for the business combination with Curatis AG -
COMMUNIQUÉ DE PRESSE
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose a Combination Transaction to reverse bankruptcy procedures, with conditions and a financing transaction. The combined entity will focus on drug development for speciality medicines. The planned transaction is subject to various approvals and closing conditions -
COMMUNIQUÉ DE PRESSE
Kinarus Therapeutics has decided to file for bankruptcy
-
COMMUNIQUÉ DE PRESSE
Kinarus Therapeutics Group Reports First Half 2023 Financial Results
-
COMMUNIQUÉ DE PRESSE
Kinarus Therapeutics signed licensing agreement to extend cash for operations
-
COMMUNIQUÉ DE PRESSE
Kinarus Therapeutics Announces Personnel Changes
-
-
COMMUNIQUÉ DE PRESSE
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity